Literature DB >> 26177421

Is Minocycline an Antiviral Agent? A Review of Current Literature.

Sandhya Nagarakanti1, Eliahu Bishburg1.   

Abstract

Minocycline is a second-generation semi-synthetic derivative of tetracycline and has well-known anti-bacterial effects. The drug possesses anti-inflammatory, anti-oxidant, anti-apoptotic and immunomodulatory effects. The drug is widely used in bacterial infections and non-infectious conditions such as acne, dermatitis, periodontitis and neurodegenerative conditions. Minocycline was shown to have antiviral activity in vitro and also against different viruses in some animal models. Some studies have been done on human patients infected with Human Immunodeficiency Virus. We have review the available data regarding minocycline activity as an antiviral agent.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177421     DOI: 10.1111/bcpt.12444

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  9 in total

1.  In Vitro and In Vivo Study on the Synergistic Effect of Minocycline and Azoles against Pathogenic Fungi.

Authors:  Lujuan Gao; Yi Sun; Mingzhu Yuan; Ming Li; Tongxiang Zeng
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

Review 2.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

3.  In Vitro Effects of Doxycycline on Replication of Feline Coronavirus.

Authors:  Magdalena Dunowska; Sayani Ghosh
Journal:  Pathogens       Date:  2021-03-07

4.  Neighborhood-based inference and restricted Boltzmann machine for microbe and drug associations prediction.

Authors:  Xiaolong Cheng; Jia Qu; Shuangbao Song; Zekang Bian
Journal:  PeerJ       Date:  2022-08-15       Impact factor: 3.061

Review 5.  Drug-Loaded Chitosan Scaffolds for Periodontal Tissue Regeneration.

Authors:  Gamal Abdel Nasser Atia; Hany K Shalaby; Mehrukh Zehravi; Mohamed Mohamady Ghobashy; Hager Abdel Nasser Attia; Zubair Ahmad; Farhat S Khan; Abhijit Dey; Nobendu Mukerjee; Athanasios Alexiou; Md Habibur Rahman; Joanna Klepacka; Agnieszka Najda
Journal:  Polymers (Basel)       Date:  2022-08-05       Impact factor: 4.967

Review 6.  Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

Authors:  Asbiel Hasbum; Jaqueline Quintanilla; Juan A Amieva Jr; May-Hui Ding; Arkene Levy; Sue Anne Chew
Journal:  Future Med Chem       Date:  2021-01-05       Impact factor: 3.808

7.  Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis.

Authors:  Chiara C Bortolasci; Wolfgang Marx; Adam J Walker; Kyoko Hasebe; Bianca E Kavanagh; Margaret J Morris; Mohammadreza Mohebbi; Alyna Turner; Laura Gray; Lesley Berk; Ken Walder; Michael Berk; Olivia M Dean
Journal:  BMJ Open       Date:  2020-03-19       Impact factor: 2.692

8.  A novel plan to deal with SARS-CoV-2 and COVID-19 disease.

Authors:  Raphael B Stricker; Melissa C Fesler
Journal:  J Med Virol       Date:  2020-06-02       Impact factor: 20.693

9.  Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations.

Authors:  Shiv Bharadwaj; Kyung Eun Lee; Vivek Dhar Dwivedi; Sang Gu Kang
Journal:  Life Sci       Date:  2020-07-09       Impact factor: 6.780

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.